Translational medicine for antibacterial drug development - A Marcus Evans conference: overcoming the challenge of proof of concept.
Chopra
Ian
I
University of Leeds, Antimicrobial Research Centre and Institute of Molecular and Cellular Biology, Leeds, LS2 9JT, UK. i.chopra@leeds.ac.uk
D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects / Q000201:enzymology; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008718:Methionine-tRNA Ligase / Q000037:antagonists & inhibitors; D012107:Research Design; D012984:Software
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D008718:Methionine-tRNA Ligase